These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1081 related articles for article (PubMed ID: 16647696)

  • 1. Cancer risk assessment for 1,3-butadiene: data integration opportunities.
    Preston RJ
    Chem Biol Interact; 2007 Mar; 166(1-3):150-5. PubMed ID: 16647696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An evaluation of the mode of action framework for mutagenic carcinogens case study: Cyclophosphamide.
    McCarroll N; Keshava N; Cimino M; Chu M; Dearfield K; Keshava C; Kligerman A; Owen R; Protzel A; Putzrath R; Schoeny R
    Environ Mol Mutagen; 2008 Mar; 49(2):117-31. PubMed ID: 18240158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mode of action in relevance of rodent liver tumors to human cancer risk.
    Holsapple MP; Pitot HC; Cohen SM; Boobis AR; Klaunig JE; Pastoor T; Dellarco VL; Dragan YP
    Toxicol Sci; 2006 Jan; 89(1):51-6. PubMed ID: 16221960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers in Czech workers exposed to 1,3-butadiene: a transitional epidemiologic study.
    Albertini RJ; Srám RJ; Vacek PM; Lynch J; Nicklas JA; van Sittert NJ; Boogaard PJ; Henderson RF; Swenberg JA; Tates AD; Ward JB; Wright M; Ammenheuser MM; Binkova B; Blackwell W; de Zwart FA; Krako D; Krone J; Megens H; Musilová P; Rajská G; Ranasinghe A; Rosenblatt JI; Rössner P; Rubes J; Sullivan L; Upton P; Zwinderman AH
    Res Rep Health Eff Inst; 2003 Jun; (116):1-141; discussion 143-62. PubMed ID: 12931846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of in vivo mutation data can inform cancer risk assessment.
    Moore MM; Heflich RH; Haber LT; Allen BC; Shipp AM; Kodell RL
    Regul Toxicol Pharmacol; 2008 Jul; 51(2):151-61. PubMed ID: 18321622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular epidemiological studies in 1,3-butadiene exposed Czech workers: female-male comparisons.
    Albertini RJ; Sram RJ; Vacek PM; Lynch J; Rossner P; Nicklas JA; McDonald JD; Boysen G; Georgieva N; Swenberg JA
    Chem Biol Interact; 2007 Mar; 166(1-3):63-77. PubMed ID: 16949064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addressing nonlinearity in the exposure-response relationship for a genotoxic carcinogen: cancer potency estimates for ethylene oxide.
    Kirman CR; Sweeney LM; Teta MJ; Sielken RL; Valdez-Flores C; Albertini RJ; Gargas ML
    Risk Anal; 2004 Oct; 24(5):1165-83. PubMed ID: 15563286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cancer risk assessment of di(2-ethylhexyl)phthalate: application of the new U.S. EPA Risk Assessment Guidelines.
    Doull J; Cattley R; Elcombe C; Lake BG; Swenberg J; Wilkinson C; Williams G; van Gemert M
    Regul Toxicol Pharmacol; 1999 Jun; 29(3):327-57. PubMed ID: 10388618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory cancer risk assessment based on a quick estimate of a benchmark dose derived from the maximum tolerated dose.
    Gaylor DW; Swirsky Gold L
    Regul Toxicol Pharmacol; 1998 Dec; 28(3):222-5. PubMed ID: 10049793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chloroform mode of action: implications for cancer risk assessment.
    Golden RJ; Holm SE; Robinson DE; Julkunen PH; Reese EA
    Regul Toxicol Pharmacol; 1997 Oct; 26(2):142-55. PubMed ID: 9356278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formaldehyde and glutaraldehyde and nasal cytotoxicity: case study within the context of the 2006 IPCS Human Framework for the Analysis of a cancer mode of action for humans.
    McGregor D; Bolt H; Cogliano V; Richter-Reichhelm HB
    Crit Rev Toxicol; 2006; 36(10):821-35. PubMed ID: 17118731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicogenomics and cancer risk assessment: a framework for key event analysis and dose-response assessment for nongenotoxic carcinogens.
    Bercu JP; Jolly RA; Flagella KM; Baker TK; Romero P; Stevens JL
    Regul Toxicol Pharmacol; 2010 Dec; 58(3):369-81. PubMed ID: 20801182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Environmental and chemical carcinogenesis.
    Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA
    Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer dose--response assessment for acrylonitrile based upon rodent brain tumor incidence: use of epidemiologic, mechanistic, and pharmacokinetic support for nonlinearity.
    Kirman CR; Gargas ML; Marsh GM; Strother DE; Klaunig JE; Collins JJ; Deskin R
    Regul Toxicol Pharmacol; 2005 Oct; 43(1):85-103. PubMed ID: 16099568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reducing uncertainty in risk assessment by using specific knowledge to replace default options.
    McClellan RO
    Drug Metab Rev; 1996; 28(1-2):149-79. PubMed ID: 8744594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethyl methanesulfonate toxicity in Viracept--a comprehensive human risk assessment based on threshold data for genotoxicity.
    Müller L; Gocke E; Lavé T; Pfister T
    Toxicol Lett; 2009 Nov; 190(3):317-29. PubMed ID: 19443141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanistic data and cancer risk assessment: the need for quantitative molecular endpoints.
    Preston RJ
    Environ Mol Mutagen; 2005; 45(2-3):214-21. PubMed ID: 15645441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a unit risk factor for 1,3-butadiene based on an updated carcinogenic toxicity assessment.
    Grant RL; Haney J; Curry AL; Honeycutt M
    Risk Anal; 2009 Dec; 29(12):1726-42. PubMed ID: 19878488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.